Factors of Compliance in Patients with Hypercholesterolemia Using Rosuvastatin in Primary Care.
10.4082/kjfm.2012.33.5.253
- Author:
Hye Young KIM
1
;
Jung Ah LEE
;
Young Sik KIM
;
Sung SUNWOO
;
Han Jin OH
;
Chang Sup KIM
;
Keunsang YUM
;
Changjin CHOI
;
Yoo Seock JEONG
;
Sang Wook SONG
;
Dae Hyun KIM
;
Young Sung KIM
Author Information
1. Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. sws@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Hypercholesterolemia;
Compliance;
Rosuvastatin;
Lipid Lowering Therapy
- MeSH:
Cholesterol;
Cholesterol, LDL;
Compliance;
Coronary Disease;
Diabetes Mellitus;
Fluorobenzenes;
Follow-Up Studies;
Humans;
Hydroxymethylglutaryl-CoA Reductase Inhibitors;
Hypercholesterolemia;
Hypertension;
Korea;
Lipoproteins;
Logistic Models;
Physicians, Family;
Primary Health Care;
Prospective Studies;
Pyrimidines;
Risk Factors;
Sulfonamides;
Rosuvastatin Calcium;
Surveys and Questionnaires
- From:Korean Journal of Family Medicine
2012;33(5):253-261
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: In order to evaluate the factors of compliance with a lipid lowering therapy, a prospective observational study of patients with hypercholesterolemia using rosuvastatin was carried out. METHODS: A total of 2,607 patients who were newly prescribed rosuvastatin were enrolled from 32 family physicians in Korea from March 2009 to December 2009. Of them, 301 patients were excluded due to incomplete data or follow-up compliance data. The patients were regularly observed to ascertain the compliance associated with rosuvastatin at intervals of 12 and 24 weeks. We collected risk factors for the compliance using a structured questionnaire. The criteria for evaluating compliance are to measure clinic attendance, to assess the continuity of therapy, and to calculate the percentage of doses taken. RESULTS: Among a total of 2,306 patients, the degree of compliance was 54.1%. According to logistic regression analysis, the factors for compliance with the lipid lowering drug included old age (odds ratio [OR], 2.68; 95% confidence interval [CI], 2.09 to 3.45), frequent exercise (OR, 1.76; 95% CI, 1.43 to 2.18), previous statin therapy (OR, 4.02; 95% CI, 3.22 to 5.01), hypertension (OR, 1.80; 95% CI, 1.48 to 2.19), diabetes mellitus (OR, 2.20; 95% CI, 1.69 to 2.87), concomitant medication (OR, 2.28; 95% CI, 1.88 to 2.77), and high coronary heart disease (CHD) risk category (OR, 1.82; 95% CI, 1.39 to 2.38). The compliance decreased with high low density lipoprotein cholesterol levels (OR, 0.20; 95% CI, 0.16 to 0.26). CONCLUSION: The compliance of patients using rosuvastatin was 54.1% in primary care. The factors related to higher compliance were old age, regular exercise, previous statin therapy, concomitant medication, presence of hypertension or diabetes, and higher CHD risk level.
